Antiangiogenic effects of marine sponge derived compounds on cancer

Area of Science:

• Oncology
• Marine Biotechnology
• Pharmacology

Background:

• The "angiogenic switch" is a critical transition in tumor progression, shifting from a dormant to a vascularized, malignant state.
• Targeting tumor angiogenesis is a key strategy in cancer therapy.
• Marine-derived compounds, particularly from sponges, show significant therapeutic potential.

Purpose of the Study:

• To review angiogenic regulators and their role in cancer.
• To highlight marine sponge-derived compounds with anti-angiogenic properties for cancer treatment.

Main Methods:

• Literature review of studies on the angiogenic switch.
• Analysis of marine sponge-derived compounds (alkaloids, terpenes, etc.) and their anti-cancer mechanisms.
• Focus on compounds inhibiting tumor angiogenesis and cell proliferation.

Main Results:

• Marine sponge compounds demonstrate significant anti-angiogenic and anti-proliferative effects.
• Specific classes of sponge-derived compounds show promise in preclinical cancer research.
• These compounds target key pathways involved in the angiogenic switch.

Conclusions:

• Marine sponge-derived compounds represent a valuable resource for developing novel anti-cancer drugs.
• Targeting the angiogenic switch with these natural products offers a promising therapeutic strategy.
• Further research into marine natural products is warranted for cancer therapy development.